Detalhe da pesquisa
1.
Low dose of sodium-glucose transporter 2 inhibitor ipragliflozin attenuated renal dysfunction and interstitial fibrosis in adenine-induced chronic kidney disease in mice without diabetes.
Metabol Open
; 7: 100049, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33015603